These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 10762579)

  • 21. Two neuraminidase inhibitors for treatment of influenza.
    Med Lett Drugs Ther; 1999 Oct; 41(1063):91-3. PubMed ID: 10535051
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial.
    LaForce C; Man CY; Henderson FW; McElhaney JE; Hampel FC; Bettis R; Kudule L; Harris J; Yates P; Tisdale M; Webster A
    Clin Ther; 2007 Aug; 29(8):1579-90; discussion 1577-8. PubMed ID: 17919541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of once daily intranasal zanamivir in preventing experimental human influenza A infection.
    Calfee DP; Peng AW; Hussey EK; Lobo M; Hayden FG
    Antivir Ther; 1999; 4(3):143-9. PubMed ID: 12731753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zanamivir. No noticeable progress against influenza.
    Can Fam Physician; 2000 Oct; 46():2003-8, 2012-8. PubMed ID: 11184246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Neuraminidase inhibitor permitted. The first pill against influenza].
    MMW Fortschr Med; 2002 Oct; 144(41):56. PubMed ID: 12474367
    [No Abstract]   [Full Text] [Related]  

  • 26. [Neuraminidase inhibitors against influenza].
    Med Monatsschr Pharm; 1999 Sep; 22(9):262-4. PubMed ID: 10536414
    [No Abstract]   [Full Text] [Related]  

  • 27. A new antiviral agent for influenza--is there a clinical niche?
    Couch RB
    N Engl J Med; 1997 Sep; 337(13):927-8. PubMed ID: 9302309
    [No Abstract]   [Full Text] [Related]  

  • 28. The use of zanamivir to treat influenza A and B infection after allogeneic stem cell transplantation.
    Johny AA; Clark A; Price N; Carrington D; Oakhill A; Marks DI
    Bone Marrow Transplant; 2002 Jan; 29(2):113-5. PubMed ID: 11850704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neuraminidase inhibitors oseltamivir and zanamivir: new means of defence against influenza].
    de Jong JC; Beyer WE; Rimmelzwaan GF; Fouchier RA; Osterhaus AD
    Ned Tijdschr Geneeskd; 2004 Jan; 148(2):73-9. PubMed ID: 14753128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nasal cytokine and chemokine responses in experimental influenza A virus infection: results of a placebo-controlled trial of intravenous zanamivir treatment.
    Fritz RS; Hayden FG; Calfee DP; Cass LM; Peng AW; Alvord WG; Strober W; Straus SE
    J Infect Dis; 1999 Sep; 180(3):586-93. PubMed ID: 10438343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of nebulized zanamivir in hospitalized patients with serious influenza.
    Ison MG; Gnann JW; Nagy-Agren S; Treannor J; Paya C; Steigbigel R; Elliott M; Weiss HL; Hayden FG;
    Antivir Ther; 2003 Jun; 8(3):183-90. PubMed ID: 12924534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elderly people's technique in using dry powder inhalers. Zanamivir and unreason seem to go together.
    Hall GH
    BMJ; 2001 Jul; 323(7303):50. PubMed ID: 11464829
    [No Abstract]   [Full Text] [Related]  

  • 33. Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial.
    Monto AS; Robinson DP; Herlocher ML; Hinson JM; Elliott MJ; Crisp A
    JAMA; 1999 Jul; 282(1):31-5. PubMed ID: 10404908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Drug regulatory agency comments on the editorial about the new influenza drugs].
    Tokola O; Pasanen M
    Duodecim; 2000; 116(6):626-7. PubMed ID: 11787114
    [No Abstract]   [Full Text] [Related]  

  • 35. [Criteria for the use of anti-influenza agents].
    Kashiwagi S
    Nihon Rinsho; 2003 Nov; 61(11):1963-6. PubMed ID: 14619439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relentless flu drug.
    Environ Health Perspect; 1998 Aug; 106(8):A372-3. PubMed ID: 9867459
    [No Abstract]   [Full Text] [Related]  

  • 37. Neuraminidase inhibitors for treatment of influenza.
    Ebell MH
    Am Fam Physician; 2004 Jun; 69(12):2824. PubMed ID: 15222647
    [No Abstract]   [Full Text] [Related]  

  • 38. Zanamivir: a significant reduction in viral load during treatment in military conscripts with influenza.
    Puhakka T; Lehti H; Vainionpää R; Jormanainen V; Pulkkinen M; Sharp S; Kerr C; Dempsey M; Ring CJ; Ward C; Tisdale M
    Scand J Infect Dis; 2003; 35(1):52-8. PubMed ID: 12685885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zanamivir for the treatment of influenza A and B infection in high-risk patients: a pooled analysis of randomized controlled trials.
    Lalezari J; Campion K; Keene O; Silagy C
    Arch Intern Med; 2001 Jan; 161(2):212-7. PubMed ID: 11176734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Zanamivir: new preparation. No tangible progress against influenza.
    Prescrire Int; 2000 Feb; 9(45):199-202. PubMed ID: 11503795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.